Medtronic (MDT) Announces Completion of Investigational Device Exemption Trial

Medtronic (MDT) announced the completion of enrollment and final treatment in its SPHERE Per-AF Trial. The FDA Investigational Device Exemption trial was designed to evaluate safety and effectiveness of Medtronic's first-of-its-kind high density mapping catheter for treatment of persistent atrial fibrillation.